شراء مباشر
قيد التنفيذ
•College of American Pathologists لإصدار شهادة إعتماد ( Accreditation) لمستشفى الملك فيصل التخصصي ومركز الأبحاث بجدة - برنامج إختبار كفاءة أداء المختبرات للتحاليل الطبية ويستخدم عينات للمراقبة المستمرة لأداء جميع تحاليل المختبرات و يتم مقارنتها بالنتائج النموذجية حيث يعتبر شرط هام من شروط الاعتماد السعودي (سباهي) و الاعتماد الدولي للمختبرات (كلية الباثولوجيا الأمريكية ) CAP is the College of American Pathologists CBAHI is Saudi Central Board for Accreditation of Healthcare Institutions
مستشفى الملك فيصل التخصصي ومركز الابحاث-جدة
رقم المنافسة
210139300600
المعرّف
#161401
| التاريخ | ميلادي | هجري |
|---|---|---|
| تاريخ النشر | 2021/01/21 07:48 | — |
| آخر موعد للاستفسارات | 2021/01/28 | 1442-06-15 |
| آخر موعد تقديم العروض | 2021/02/07 09:00 | 1442-06-25 |
| موعد فتح العروض | — | |
| موعد فحص العروض | — | — |
| التاريخ المتوقع للترسية | — | — |
| تاريخ بدء الأعمال | — | — |
| تاريخ خطاب تأكيد المشاركة | — | — |
| بداية إرسال الأسئلة | — | — |
موقع التنفيذ
مجال التصنيف
جدول 1 المواد - توريد مستلزمات طبية
| الاسم | البند | الرقم | الفئة | الكمية | الوحدة | رقم البند | منتج من القائمة الإلزامية | ملف البند |
|---|---|---|---|---|---|---|---|---|
| Performance Improvement Program in Surgical Pathology | Performance Improvement Program in Surgical Pathology | 1 | PIP | 1 | KIT | 1 | 0 | Copy of توريد مستلزمات طبية - المواد.pdf 387 KB |
| Performance Improvement Program in Surgical Pathology, Additional Pathologist | Performance Improvement Program in Surgical Pathology, Additional Pathologist | 2 | PIP1 | 12 | KIT | 2 | 0 | — |
| CAP/NSH HistoQIP | CAP/NSH HistoQIP | 3 | HQIP | 1 | KIT | 3 | 0 | — |
| Immunohistochemistry | Immunohistochemistry | 4 | MK | 1 | KIT | 4 | 0 | — |
| HER2 Immunohistochemistry | HER2 Immunohistochemistry | 5 | HER2 | 1 | KIT | 5 | 0 | — |
| ER/PgR, IHC Tissue Microarray | ER/PgR, IHC Tissue Microarray | 6 | PM2 | 1 | Kit | 6 | 0 | — |
| Cytopathology Glass Slide Education Program | Cytopathology Glass Slide Education Program | 7 | PAP JE1 | 1 | KIT | 7 | 0 | — |
| Cytopathology Glass Slide Education Program | Cytopathology Glass Slide Education Program | 8 | APAP JE1 | 13 | KIT | 8 | 0 | — |
| Fine-Needle Aspiration Glass Slides, Laboratory | Fine-Needle Aspiration Glass Slides, Laboratory | 9 | FNAG | 1 | KIT | 9 | 0 | — |
| Fine-Needle Aspiration Glass Slides, Individual | Fine-Needle Aspiration Glass Slides, Individual | 10 | FNAG1 | 11 | KIT | 10 | 0 | — |
| Non-GYN Interlaboratory Comparison, Lab | Non-GYN Interlaboratory Comparison, Lab | 11 | NGC | 1 | KIT | 11 | 0 | — |
| Non-GYN Interlaboratory Comparison, Indv | Non-GYN Interlaboratory Comparison, Indv | 12 | NGC1 | 11 | KIT | 12 | 0 | — |
| Antibody Titer, Anti-A and Anti-D | Antibody Titer, Anti-A and Anti-D | 13 | ABT | 1 | KIT | 13 | 0 | — |
| Antibody Titer, Anti-B | Antibody Titer, Anti-B | 14 | ABT3 | 1 | KIT | 14 | 0 | — |
| Eluate | Eluate | 15 | ELU | 1 | KIT | 15 | 0 | — |
| Expanded Transfusion Medicine Exercises | Expanded Transfusion Medicine Exercises | 16 | ETME1 | 1 | KIT | 16 | 0 | — |
| Fetal Red Cell Detection | Fetal Red Cell Detection | 17 | HBF | 1 | KIT | 17 | 0 | — |
| Waived Combination | Waived Combination | 18 | HCC | 3 | KIT | 18 | 0 | — |
| Transfusion Medicine— Automated | Transfusion Medicine— Automated | 19 | JAT | 1 | KIT | 19 | 0 | — |
| Sickle Cell Screening | Sickle Cell Screening | 20 | SCS | 1 | KIT | 20 | 0 | — |
| Transfusion Medicine Comprehensive—Competency Assessment | Transfusion Medicine Comprehensive—Competency Assessment | 21 | TMCA | 1 | KIT | 21 | 0 | — |
| Direct Antiglobulin Test— Competency Assessment | Direct Antiglobulin Test— Competency Assessment | 22 | TMCAD | 1 | KIT | 22 | 0 | — |
| Fetal Red Cell Quantitation— Competency Assessment | Fetal Red Cell Quantitation— Competency Assessment | 23 | TMCAF | 1 | KIT | 23 | 0 | — |
| Eluate Competency Assessment | Eluate Competency Assessment | 24 | TMCAE | 1 | KIT | 24 | 0 | — |
| Direct Antiglobulin Testing | Direct Antiglobulin Testing | 25 | DAT | 1 | KIT | 25 | 0 | — |
| Transfusion Medicine— Comprehensive | Transfusion Medicine— Comprehensive | 26 | J | 1 | KIT | 26 | 0 | — |
| Transfusion Medicine—Education Challenge | Transfusion Medicine—Education Challenge | 27 | JE1 | 1 | KIT | 27 | 0 | — |
| Red Blood Cell Antigen Typing | Red Blood Cell Antigen Typing | 28 | RBCAT | 1 | KIT | 28 | 0 | — |
| Viral Markers—Series 1 | Viral Markers—Series 1 | 29 | VM1 | 2 | KIT | 29 | 0 | — |
| Viral Markers—Series 3 | Viral Markers—Series 3 | 30 | VM3 | 2 | KIT | 30 | 0 | — |
| Viral Markers—Series 5 | Viral Markers—Series 5 | 31 | VM5 | 2 | KIT | 31 | 0 | — |
| Viral Markers—Series 6 | Viral Markers—Series 6 | 32 | VM6 | 1 | KIT | 32 | 0 | — |
| Syphilis Serology | Syphilis Serology | 33 | G | 2 | KIT | 33 | 0 | — |
| Nucleic Acid Testing | Nucleic Acid Testing | 34 | NAT | 1 | KIT | 34 | 0 | — |
| CAP/AACC Serum Alcohol/Volatiles | CAP/AACC Serum Alcohol/Volatiles | 35 | AL2 | 1 | KIT | 35 | 0 | — |
| B-Type Natriuretic Peptides, 5 Challenge | B-Type Natriuretic Peptides, 5 Challenge | 36 | BNP5 | 1 | KIT | 36 | 0 | — |
| Cardiac Markers | Cardiac Markers | 37 | CRT | 1 | KIT | 37 | 0 | — |
| Cystatin C | Cystatin C | 38 | CYS | 1 | KIT | 38 | 0 | — |
| Chemistry/Therapeutic Drug Monitoring | Chemistry/Therapeutic Drug Monitoring | 39 | CZ | 1 | KIT | 39 | 0 | — |
| Quality Cross Check—Chemistry/ Therapeutic Drug Monitoring | Quality Cross Check—Chemistry/ Therapeutic Drug Monitoring | 40 | CZQ | 1 | KIT | 40 | 0 | — |
| Body Fluid Chemistry | Body Fluid Chemistry | 41 | FLD | 1 | KIT | 41 | 0 | — |
| Body Fluid Chemistry 2 | Body Fluid Chemistry 2 | 42 | FLD2 | 1 | KIT | 42 | 0 | — |
| Hemoglobin A1c, 5 Challenge | Hemoglobin A1c, 5 Challenge | 43 | GH5 | 1 | KIT | 43 | 0 | — |
| High-Sensitivity C-Reactive Protein | High-Sensitivity C-Reactive Protein | 44 | HSCRP | 1 | KIT | 44 | 0 | — |
| Immunology—General | Immunology—General | 45 | IG | 1 | KIT | 45 | 0 | — |
| Insulin, Gastrin, C-Peptide, and PTH | Insulin, Gastrin, C-Peptide, and PTH | 46 | ING | 1 | KIT | 46 | 0 | — |
| Ligand—General | Ligand—General | 47 | K | 1 | KIT | 47 | 0 | — |
| Ketones | Ketones | 48 | KET | 1 | KIT | 48 | 0 | — |
| Cerebrospinal Fluid Chemistry | Cerebrospinal Fluid Chemistry | 49 | M | 1 | KIT | 49 | 0 | — |
| Neonatal Bilirubin, 2 Challenge | Neonatal Bilirubin, 2 Challenge | 50 | NB2 | 1 | KIT | 50 | 0 | — |
| Procalcitonin | Procalcitonin | 51 | PCT | 1 | KIT | 51 | 0 | — |
| Renin and Aldosterone | Renin and Aldosterone | 52 | RAP | 1 | KIT | 52 | 0 | — |
| Rheumatoid Factor | Rheumatoid Factor | 53 | RF | 1 | KIT | 53 | 0 | — |
| Immunology—Special, Limited | Immunology—Special, Limited | 54 | S4 | 1 | KIT | 54 | 0 | — |
| Tumor Markers | Tumor Markers | 55 | TM | 1 | KIT | 55 | 0 | — |
| High-Sensitivity Cardiac Markers TNT | High-Sensitivity Cardiac Markers TNT | 56 | HTNT | 1 | KIT | 56 | 0 | — |
| Urine Chemistry—General | Urine Chemistry—General | 57 | U | 1 | KIT | 57 | 0 | — |
| CAP/AACC Urine Drug Testing, Screening | CAP/AACC Urine Drug Testing, Screening | 58 | UDS | 1 | KIT | 58 | 0 | — |
| 25-OH Vitamin D, Total | 25-OH Viamin D, Total | 59 | VITD | 1 | KIT | 59 | 0 | — |
| Ligand—Special | Ligand—Specia | 60 | Y | 1 | KIT | 60 | 0 | — |
| Chemistry, Lipid, Enzyme Calibration Verification/Linearity | Chemistry, Lipid, Enzyme Calibration Verification/Linearity | 61 | LN2 | 1 | KIT | 61 | 0 | — |
| Therapeutic Drug Monitoring Calibration Verification/Linearity | Therapeutic Drug Monitoring Calibration Verification/Linearity | 62 | LN3 | 1 | KIT | 62 | 0 | — |
| Ligand Assay Calibration Verification/Linearity | Ligand Assay Calibration Verification/Linearity | 63 | LN5 | 1 | KIT | 63 | 0 | — |
| Urine Chemistry Calibration Verification/Linearity | Urine Chemistry Calibration Verification/Linearity | 64 | LN6 | 1 | KIT | 64 | 0 | — |
| Immunology Calibration Verification/Linearity | Immunology Calibration Verification/Linearity | 65 | LN7 | 1 | KIT | 65 | 0 | — |
| Reproductive Endocrinology Calibration Verification/Linearity | Reproductive Endocrinology Calibration Verification/Linearity | 66 | LN8 | 1 | KIT | 66 | 0 | — |
| Serum Ethanol Calibration Verification/Linearity | Serum Ethanol Calibration Verification/Linearity | 67 | LN11 | 1 | KIT | 67 | 0 | — |
| Hemoglobin A1c Accuracy Calibration Verification/Linearity | Hemoglobin A1c Accuracy Calibration Verification/Linearity | 68 | LN15 | 1 | KIT | 68 | 0 | — |
| Urine Albumin Calibration Verification/Linearity | Urine Albumin Calibration Verification/Linearity | 69 | LN20 | 1 | KIT | 69 | 0 | — |
| High-Sensitivity CRP Calibration Verification/Linearity | High-Sensitivity CRP Calibration Verification/Linearity | 70 | LN21 | 1 | KIT | 70 | 0 | — |
| Prostate-Specific Antigen Calibration Verification/Linearity | Prostate-Specific Antigen Calibration Verification/Linearity | 71 | LN23 | 1 | KIT | 71 | 0 | — |
| Creatinine Accuracy Calibration Verification/Linearity | Creatinine Accuracy Calibration Verification/Linearity | 72 | LN24 | 1 | KIT | 72 | 0 | — |
| Troponin T Calibration Verification/Linearity | Troponin T Calibration Verification/Linearity | 73 | LN27 | 1 | KIT | 73 | 0 | — |
| B-Type Natriuretic Peptides Calibration Verification/Linearity | B-Type Natriuretic Peptides Calibration Verification/Linearity | 74 | LN30 | 1 | KIT | 74 | 0 | — |
| Ammonia Calibration Verification/ Linearity | Ammonia Calibration Verification/ Linearity | 75 | LN32 | 1 | KIT | 75 | 0 | — |
| Tumor Markers Calibration Verification/Linearity | Tumor Markers Calibration Verification/Linearity | 76 | LN34 | 1 | KIT | 76 | 0 | — |
| Vitamin D Calibration Verification/ Linearity | Vitamin D Calibration Verification/ Linearity | 77 | LN40 | 1 | KIT | 77 | 0 | — |
| Procalcitonin Calibration Verification/Linearity | Procalcitonin Calibration Verification/Linearity | 78 | LN41 | 1 | KIT | 78 | 0 | — |
| CAP/ACMG Cytogenetics, Online Images | CAP/ACMG Cytogenetics, Online Images | 79 | CY | 1 | KIT | 79 | 0 | — |
| Flow Cytometry Combo (FL1/FL2) | Flow Cytometry Combo (FL1/FL2) | 80 | FL | 1 | KIT | 80 | 0 | — |
| Flow Immunophenotypic Characterization of Leukemia/ Lymphoma | Flow Immunophenotypic Characterization of Leukemia/ Lymphoma | 81 | FL3 | 1 | KIT | 81 | 0 | — |
| Flow Cytometry, CD34+ | Flow Cytometry, CD34+ | 82 | FL4 | 1 | KIT | 82 | 0 | — |
| Flow Cytometry, Interpretation Only | Flow Cytometry, Interpretation Only | 83 | FL5 | 1 | KIT | 83 | 0 | — |
| Flow Cytometry—B-ALL Minimal Residual Disease | Flow Cytometry—B-ALL Minimal Residual Disease | 84 | BALL | 1 | KIT | 84 | 0 | — |
| Flow Cytometry—PNH Immunophenotyping | Flow Cytometry—PNH Immunophenotyping | 85 | PNH | 1 | KIT | 85 | 0 | — |
| Rare Flow Antigen Validation, CD1a | Rare Flow Antigen Validation, CD1a | 86 | RFAV1 | 1 | KIT | 86 | 0 | — |
| Rare Flow Antigen Validation, CD103 | Rare Flow Antigen Validation, CD103 | 87 | RFAV2 | 1 | KIT | 87 | 0 | — |
| Transfusion-Related Cell Count | Transfusion-Related Cell Count | 88 | TRC | 1 | KIT | 88 | 0 | — |
| Flow Cytometry Calibration | Flow Cytometry Calibration | 89 | LN22 | 2 | KIT | 89 | 0 | — |
| Verification/Linearity | Verification/Linearity | 90 | LN22 | 2 | KIT | 90 | 0 | — |
| Flow Cytometry—Plasma Cell Neoplasms | Flow Cytometry—Plasma Cell Neoplasms | 91 | PCNEO | 1 | KIT | 91 | 0 | — |
| Fetal Hemoglobin | Fetal Hemoglobin | 92 | APT | 1 | KIT | 92 | 0 | — |
| Body Fluid Crystals | Body Fluid Crystals | 93 | BFC | 1 | KIT | 93 | 0 | — |
| Automated Body Fluid | Automated Body Fluid | 94 | ABF2 | 1 | KIT | 94 | 0 | — |
| Bone Marrow Cell Differential | Bone Marrow Cell Differential | 95 | BMD | 1 | KIT | 95 | 0 | — |
| Blood Parasite | Blood Parasite | 96 | BP | 1 | KIT | 96 | 0 | — |
| Coagulation—Extended | Coagulation—Extended | 97 | CGE | 2 | KIT | 97 | 0 | — |
| Coagulation—Limited | Coagulation—Limited | 98 | CGL | 2 | KIT | 89 | 0 | — |
| Coagulation—Limited, Validated Material | Coagulation—Limited, Validated Material | 99 | CGM | 1 | KIT | 99 | 0 | — |
| Lupus Anticoagulant and Mixing Studies | Lupus Anticoagulant and Mixing StudiesLupus Anticoagulant and Mixing Studies | 100 | CGS1 | 2 | KIT | 100 | 0 | — |
| Thrombophilia | Thrombophilia | 101 | CGS2 | 2 | KIT | 101 | 0 | — |
| Heparin | Heparin | 102 | CGS4 | 2 | KIT | 102 | 0 | — |
| Expanded Virtual Peripheral Blood Smear | Expanded Virtual Peripheral Blood Smear | 103 | EHE1 | 1 | KIT | 103 | 0 | — |
| Erythrocyte Sedimentation Rate | Erythrocyte Sedimentation Rate | 104 | ESR | 1 | KIT | 104 | 0 | — |
| Hemocytometer Fluid Count, International | Hemocytometer Fluid Count, International | 105 | HFCI | 1 | KIT | 105 | 0 | — |
| Quality Cross Check—Hematology | Quality Cross Check—Hematology | 106 | FH9Q | 1 | KIT | 106 | 0 | — |
| Hematology Automated Differential Series | Hematology Automated Differential Series | 107 | FH9 | 2 | KIT | 107 | 0 | — |
| Hemoglobinopathy | Hemoglobinopathy | 108 | HG | 1 | KIT | 108 | 0 | — |
| Hematopathology Online Education | Hematopathology Online Education | 109 | HPATH | 1 | KIT | 109 | 0 | — |
| Reticulocyte Calibration Verification/Linearity | Reticulocyte Calibration Verification/Linearity | 110 | LN18 | 2 | KIT | 110 | 0 | — |
| Thrombophilia Calibration Verification/Linearity | Thrombophilia Calibration Verification/Linearity | 111 | LN35 | 2 | KIT | 111 | 0 | — |
| Heparin Calibration Verification/ Linearity | Heparin Calibration Verification/ Linearity | 112 | LN36 | 2 | KIT | 112 | 0 | — |
| D-Dimer Calibration Verification/ Linearity | D-Dimer Calibration Verification/ Linearity | 113 | LN42 | 2 | KIT | 113 | 0 | — |
| Hematology Calibration Verification/Linearity | Hematology Calibration Verification/Linearity | 114 | LN9 | 2 | KIT | 114 | 0 | — |
| Platelet Function | Platelet Function | 115 | PF1 | 1 | KIT | 115 | 0 | — |
| Reticulocyte | Reticulocyte | 116 | RT4 | 2 | KIT | 116 | 0 | — |
| Virtual Body Fluid | Virtual Body Fluid | 117 | VBF | 1 | KIT | 117 | 0 | — |
| Blood Cell ID, Photographs | Blood Cell ID, Photographs | 118 | BCP | 1 | KIT | 118 | 0 | — |
| Glucose-6-Phosphate Dehydrogenase | Glucose-6-Phosphate Dehydrogenase | 119 | G6PDS | 1 | KIT | 119 | 0 | — |
| HLA Crossmatching, Antibody Screen, and Antibody Identification (Class I/Class II) | HLA Crossmatching, Antibody Screen, and Antibody Identification (Class I/Class II) | 120 | MXC | 2 | KIT | 120 | 0 | — |
| Class I & II HLA Molecular Typing | Class I & II HLA Molecular Typing | 121 | DML | 2 | KIT | 121 | 0 | — |
| Bacteriology | Bacteriology | 122 | D | 1 | KIT | 122 | 0 | — |
| Blood Culture | Blood Culture | 123 | BCS | 1 | KIT | 123 | 0 | — |
| Mycobacteriology | Mycobacteriology | 124 | E | 1 | KIT | 124 | 0 | — |
| Mycology and Aerobic Actinomycetes | Mycology and Aerobic Actinomycetes | 125 | F | 1 | KIT | 125 | 0 | — |
| India Ink | India Ink | 126 | IND | 1 | KIT | 126 | 0 | — |
| Parasitology | Parasitology | 127 | P | 1 | KIT | 127 | 0 | — |
| Urinalysis w/Body Fluid & Urine Sediment Photos | Urinalysis w/Body Fluid & Urine Sediment Photos | 128 | CMP | 9 | KIT | 128 | 0 | — |
| Fecal Fat | Fecal Fat | 129 | FCFS | 1 | KIT | 129 | 0 | — |
| Bacterial Detection in Platelets, 2 Challenge | Bacterial Detection in Platelets, 2 Challenge | 130 | BDP | 1 | KIT | 130 | 0 | — |
| Nucleic Acid Amplification, Organisms | Nucleic Acid Amplification, Organisms | 131 | IDO | 2 | KIT | 131 | 0 | — |
| Vancomycin-resistant Enterococcus | Vancomycin-resistant Enterococcus | 132 | VRE | 1 | KIT | 132 | 0 | — |
| Methicillin-resistant Staphylococcus aureus, 2 Challenge | Methicillin-resistant Staphylococcus aureus, 2 Challenge | 133 | MRS | 1 | KIT | 133 | 0 | — |
| Clinical Microscopy Miscellaneous Photopage | Clinical Microscopy Miscellaneous Photopage | 134 | CMMP | 1 | KIT | 134 | 0 | — |
| Occult Blood | Occult Blood | 135 | OCB | 1 | KIT | 135 | 0 | — |
| Molecular MTB Detection and Resistance | Molecular MTB Detection and Resistance | 136 | MTBR | 1 | KIT | 136 | 0 | — |
| C. diff, 2 Challenge | C. diff, 2 Challenge | 137 | CDF2 | 1 | KIT | 137 | 0 | — |
| Micro Bench Tools Competency | Micro Bench Tools Competency | 138 | MBT | 1 | KIT | 138 | 0 | — |
| Vaginitis Screen, Virtual Gram Stain | Vaginitis Screen, Virtual Gram Stain | 139 | VS2 | 1 | KIT | 139 | 0 | — |
| Carbapenem-resistant Organisms | Carbapenem-resistant Organisms | 140 | CRO | 1 | KIT | 140 | 0 | — |
| Virtual Gram Stain Advanced Competency | Virtual Gram Stain Advanced Competency | 141 | VGS2 | 1 | KIT | 141 | 0 | — |
| Meningitis/Encephalitis Panel | Meningitis/Encephalitis Panel | 142 | IDME | 1 | KIT | 142 | 0 | — |
| Gastrointestinal Panel, 2 Challenge | Gastrointestinal Panel, 2 Challenge | 143 | GIP | 1 | KIT | 143 | 0 | — |
| Infectious Disease, Pneumonia Panel | Infectious Disease, Pneumonia Panel | 144 | IDPN | 1 | KIT | 144 | 0 | — |
| Bacterial Blood Culture, Molecular | Bacterial Blood Culture, Molecular | 145 | BCM | 1 | KIT | 145 | 0 | — |
| Hepatitis C Viral Load | Hepatitis C Viral Load | 146 | HCV2 | 1 | KIT | 146 | 0 | — |
| Hepatitis B Viral Load, 5 Challenge | Hepatitis B Viral Load, 5 Challenge | 147 | HBVL5 | 1 | KIT | 147 | 0 | — |
| HIV Viral Load | HIV Viral Load | 148 | HV2 | 1 | KIT | 148 | 0 | — |
| Viral Load | Viral Load | 149 | VLS2 | 1 | KIT | 149 | 0 | — |
| CMV Viral Load Calibration Verification/Linearity | CMV Viral Load Calibration Verification/Linearity | 150 | LN38 | 1 | KIT | 150 | 0 | — |
| HIV Viral Load Calibration Verification/Linearity | HIV Viral Load Calibration Verification/Linearity | 151 | LN39 | 1 | KIT | 151 | 0 | — |
| HCV Viral Load Calibration Verification/Linearity | HCV Viral Load Calibration Verification/Linearity | 152 | LN45 | 1 | KIT | 152 | 0 | — |
| Infectious Disease, Respiratory Panel | Infectious Disease, Respiratory Panel | 153 | IDR | 1 | KIT | 153 | 0 | — |
| Influenza A, Influenza B, and RSV by NAA | Influenza A, Influenza B, and RSV by NAA | 154 | ID3 | 1 | KIT | 154 | 0 | — |
| SARS-CoV-2, Molecular | SARS-CoV-2, Molecular | 155 | COV2 | 1 | KIT | 155 | 0 | — |
| Activated Clotting Time | Activated Clotting Time | 156 | CT2 | 6 | KIT | 156 | 0 | — |
| Activated Clotting Time | Activated Clotting Time | 157 | CT3 | 4 | KIT | 157 | 0 | — |
| Blood Gas/Critical Care Calibration Verification/Linearity | Blood Gas/Critical Care Calibration Verification/Linearity | 158 | LN13C | 7 | KIT | 158 | 0 | — |
| Critical Care Blood Gas with Chemistry | Critical Care Blood Gas with Chemistry | 159 | AQ2 | 7 | KIT | 159 | 0 | — |
| Whole Blood Glucose Calibration Verification/Linearity | Whole Blood Glucose Calibration Verification/Linearity | 160 | LN17 | 7 | KIT | 160 | 0 | — |
| Quality Cross Check—Whole Blood Glucose | Quality Cross Check—Whole Blood Glucose | 161 | WBGQ | 3 | KIT | 161 | 0 | — |
| Blood Oximetry | Blood Oximetry | 162 | SO | 7 | KIT | 162 | 0 | — |
| Viscoelastic Studies | Viscoelastic Studies | 163 | VES | 1 | KIT | 163 | 0 | — |
| Critical Care Blood Gas with Chemistry, i-STAT | Critical Care Blood Gas with Chemistry, i-STAT | 164 | AQ4 | 2 | KIT | 164 | 0 | — |
| Infectious Disease Serology | Infectious Disease Serology | 165 | VR3 | 1 | KIT | 165 | 0 | — |
| Infectious Disease Serology, Mumps | Infectious Disease Serology, Mumps | 166 | VR3M | 1 | KIT | 166 | 0 | — |
| Antinuclear Antibody | Antinuclear Antibody | 167 | ANA | 1 | KIT | 167 | 0 | — |
| Rubella | Rubella | 168 | RUB | 1 | KIT | 168 | 0 | — |
| Infectious Mononucleosis | Infectious Mononucleosis | 169 | IM | 1 | KIT | 169 | 0 | — |
| Antiphosphatidylserine Antibody | Antiphosphatidylserine Antibody | 170 | APS | 1 | KIT | 170 | 0 | — |
| Cyclic Citrullinated Peptide Antibody (Anti- CCP) | Cyclic Citrullinated Peptide Antibody (Anti- CCP) | 171 | CCP | 1 | KIT | 171 | 0 | — |
| Viral Markers—Series 2 | Viral Markers—Series 2 | 172 | VM2 | 1 | KIT | 172 | 0 | — |
| CAP/AACC Immunosuppressive Drugs | CAP/AACC Immunosuppressive Drugs | 173 | CS | 1 | KIT | 173 | 0 | — |
| Immunosuppressive Drugs Calibration Verification/Linearity | Immunosuppressive Drugs Calibration Verification/Linearity | 174 | LN31 | 1 | KIT | 174 | 0 | — |
| Immunology—Special | Immunology—Special | 175 | S2 | 1 | KIT | 175 | 0 | — |
| Rheumatic Disease Special Serologies | Rheumatic Disease Special Serologies | 176 | RDS | 1 | KIT | 176 | 0 | — |
| M. tuberculosis-Stimulated Infection Detection | M. tuberculosis-Stimulated Infection Detection | 177 | QF | 1 | KIT | 177 | 0 | — |
| Physician Satisfaction with Clinical Laboratory Services | Physician Satisfaction with Clinical Laboratory Services | 178 | QP213 | 1 | KIT | 178 | 0 | — |
| Blood Culture Contamination | Blood Culture Contamination | 179 | QT2 | 1 | KIT | 179 | 0 | — |
| In-Date Blood Product Wastage | In-Date Blood Product Wastage | 180 | QT4 | 1 | KIT | 180 | 0 | — |
| Critical Values Reporting | Critical Values Reporting | 181 | QT10 | 1 | KIT | 181 | 0 | — |
| Corrected Results | Corrected Results | 182 | QT16 | 1 | KIT | 182 | 0 | — |
| Competency Assessment Program | Competency Assessment Program | 183 | CA0250 | 1 | KIT | 183 | 0 | — |
| Safety & Compliance Courses* | Safety & Compliance Courses* | 184 | XCA0250 | 1 | KIT | 184 | 0 | Copy of توريد مستلزمات طبية - المواد.pdf 387 KB |
184 بند
كراسة الشروط الرئيسية
كراسة الشروط والمواصفات وملاحق المنافسة
1.3 MB
تم التحميل
2021/161401/main_booklet_كراسة_الشروط.html
المستندات الداعمة (5 ملف)
جدول الشحن.pdf
962 KB
تم التحميل
2021/161401/idd_506212C4-EAC5-CD00-8749-7719F6E00000_جدول_الشحن.pdf
نموذج كراسة الشروط والمواصفات.pdf
1.4 MB
تم التحميل
2021/161401/idd_64F5C94B-793D-CFD0-85A4-7719F7600000_نموذج_كراسة_الشروط_والمواصفات.pdf
نموذج العقد .pdf
1.6 MB
تم التحميل
2021/161401/idd_7E11C82A-87DB-C436-863D-7719F7800000_نموذج_العقد_.pdf
Copy of توريد مستلزمات طبية - المواد.pdf
387 KB
تم التحميل
2021/161401/idd_97C7C9A2-FD2D-C8FC-8552-7719F7100000_Copy_of_توريد_مستلزمات_طبية_-_المواد.pdf
1.scope of work.pdf
895 KB
تم التحميل
2021/161401/idd_E726106F-2CCD-C8EA-84E8-7719F6C00000_1.scope_of_work.pdf
لم يتم ترسية هذه المنافسة بعد
لا توجد بيانات للمحتوى المحلي
معايير التقييم
لا توجد معايير تقييم
أخبار المنافسة
لا توجد أخبار